Implementation of Teledermoscopy and Artificial Intelligence
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study has 2 parts. Part 1 will investigate the effects of introducing teledermoscopy in clinical practice, more specifically the change in referral patterns, the risk of undetected skin cancers and the effect on diagnostic accuracy in general practitioners. Part 2 will create artificial intelligence (AI) as support tools for teledermocsopic assessors and investigate the effect of introducing AI within teledermocsopy. In this study the investigators will measure the diagnostic accuracy of teledermoscopic assessors that had access to the results of artificial intelligence algorithm compared to those who did not. Data will be collected through teledermoscopic referrals, patient records, national registries and questionnairs.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Ma zmianę skórną ocenioną przez lekarza podczas wizyty
- •Lekarz zdecydował się wysłać zdjęcie zmiany do teledermatoskopii
✗ Disqualifies
- •Nie chce lub nie może uczestniczyć w badaniu
- •Jest poniżej 15 lat
- •Zdjęcia są tak niskiej jakości, że nie można ich ocenić
Simplified criteria — AI translation
Trial details
- Minimum age
- 15 Years
- Last updated (source)
- October 16, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Department of dermatology, Skane University Hospital
Lund, Sweden
Trial contact
Asa Ingvar, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/17/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.